Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV)

NCT00858923 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV
HIV Infections

Interventions

DEVICE: Energex HemoModulator

Sponsor

Energex Systems, Inc.